Illness	Number of cases
Other affections of the retina - Degeneration of the macula and posterior pole - Other degeneration of the macula and posterior pole (H35.38)	43
Corneal scars and opacities - Unspecified corneal scar and opacity (H17.9)	8
Other disorders of conjunctiva (H11.0)	not specified
Other disorders of cornea (H18.5)	not specified
Other cataract - Other specified cataract (H26.8)	not specified
Other cataract - Unspecified cataract (H26.9)	not specified
Other disorders of lens (H27.0)	not specified
Other disorders of lens (H27.1)	not specified
Glaucoma (H40.1)	not specified

Top 10 treatments

Treatment	Number
Surgical removal and subsequent replacement of the vitreous of the eye with access via the ciliary body (5-158.21)	33
Operation using aids for optical magnification, e.g. magnifying spectacles, operating microscope (5-984)	9
Transplantation of an artificial graft to replace the cornea of the eye (5-125.10)	6
Reduction of the intraocular pressure by improving aqueous humour circulation (5-133.0)	4
Surgical removal and subsequent replacement of the vitreous of the eye with access via the ciliary body (5-158.22)	4
Surgical replacement of the conjunctiva of the eye (5-113.00)	0
Operation for triangular conjunctival folds in the crease of the eyelid (pterygium) (5-122.0)	0
Transplantation of an artificial graft to replace the cornea of the eye (5-125.01)	0
Reduction of the intraocular pressure by means of an operation on the ciliary body (5-132.21)	0
Surgery for the opacity of a lens after a cataract operation (secondary cataract) (5-142.2)	0

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2700

Type of specialist department

Inpatient department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
21	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
21	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
21	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility